<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37433796</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>11</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Comparison of commercially available differentiation media on cell morphology, function, and anti-viral responses in conditionally reprogrammed human bronchial epithelial cells.</ArticleTitle><Pagination><StartPage>11200</StartPage><MedlinePgn>11200</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">11200</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-37828-0</ELocationID><Abstract><AbstractText>Primary air liquid interface (ALI) cultures of bronchial epithelial cells are used extensively to model airway responses. A recent advance is the development of conditional reprogramming that enhances proliferative capability. Several different media and protocols are utilized, yet even subtle differences may influence cellular responses. We compared the morphology and functional responses, including innate immune responses to rhinovirus infection in conditionally reprogrammed primary bronchial epithelial cells (pBECs) differentiated using two commonly used culture media. pBECs collected from healthy donors (n = 5) were CR using g-irradiated 3T3 fibroblasts and Rho Kinase inhibitor. CRpBECs were differentiated at ALI in either PneumaCult (PN-ALI) or bronchial epithelial growth medium (BEGM)-based differentiation media (BEBM:DMEM, 50:50, Lonza)-(AB-ALI) for 28 days. Transepithelial electrical resistance (TEER), immunofluorescence, histology, cilia activity, ion channel function, and expression of cell markers were analyzed. Viral RNA was assessed by RT-qPCR and anti-viral proteins quantified by LEGENDplex following Rhinovirus-A1b infection. CRpBECs differentiated in PneumaCult were smaller and had a lower TEER and cilia beat frequency compared to BEGM media. PneumaCult media cultures exhibited increased FOXJ1 expression, more ciliated cells with a larger active area, increased intracellular mucins, and increased calcium-activated chloride channel current. However, there were no significant changes in viral RNA or host antiviral responses. There are distinct structural and functional differences in pBECs cultured in the two commonly used ALI differentiation media. Such factors need to be taken into consideration when designing CRpBECs ALI experiments for specific research questions.</AbstractText><CopyrightInformation>© 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Awatade</LastName><ForeName>Nikhil T</ForeName><Initials>NT</Initials><AffiliationInfo><Affiliation>School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia. nikhil.awatade@newcastle.edu.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immune Health Program, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, NSW, Australia. nikhil.awatade@newcastle.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reid</LastName><ForeName>Andrew T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Asthma and Breathing Research Program, Hunter Medical Research Institute University of Newcastle, New Lambton Heights, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nichol</LastName><ForeName>Kristy S</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immune Health Program, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Budden</LastName><ForeName>Kurtis F</ForeName><Initials>KF</Initials><AffiliationInfo><Affiliation>School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immune Health Program, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veerati</LastName><ForeName>Punnam Chander</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Asthma and Breathing Research Program, Hunter Medical Research Institute University of Newcastle, New Lambton Heights, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pathinayake</LastName><ForeName>Prabuddha S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immune Health Program, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grainge</LastName><ForeName>Christopher L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Asthma and Breathing Research Program, Hunter Medical Research Institute University of Newcastle, New Lambton Heights, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dept of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton Heights, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hansbro</LastName><ForeName>Philip M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Immune Health Program, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wark</LastName><ForeName>Peter A B</ForeName><Initials>PAB</Initials><AffiliationInfo><Affiliation>School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia. peter.wark@newcastle.edu.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immune Health Program, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, NSW, Australia. peter.wark@newcastle.edu.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Asthma and Breathing Research Program, Hunter Medical Research Institute University of Newcastle, New Lambton Heights, NSW, Australia. peter.wark@newcastle.edu.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dept of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton Heights, NSW, Australia. peter.wark@newcastle.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018118">Chloride Channels</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003470">Culture Media</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001980" MajorTopicYN="Y">Bronchi</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004847" MajorTopicYN="N">Epithelial Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018118" MajorTopicYN="N">Chloride Channels</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002923" MajorTopicYN="N">Cilia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003470" MajorTopicYN="N">Culture Media</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>12</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>11</Day><Hour>23</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37433796</ArticleId><ArticleId IdType="pmc">PMC10336057</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-37828-0</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-37828-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kesimer M, Kirkham S, Pickles RJ, Henderson AG, Alexis NE, Demaria G, et al. Tracheobronchial air-liquid interface cell culture: A model for innate mucosal defense of the upper airways? Am. J. Physiol. Lung Cell Mol. Physiol. 2009;296(1):L92–100. doi: 10.1152/ajplung.90388.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.90388.2008</ArticleId><ArticleId IdType="pmc">PMC2636953</ArticleId><ArticleId IdType="pubmed">18931053</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezzulo AA, Starner TD, Scheetz TE, Traver GL, Tilley AE, Harvey BG, et al. The air–liquid interface and use of primary cell cultures are important to recapitulate the transcriptional profile of in vivo airway epithelia. Am. J. Physiol. Lung Cell Mol. Physiol. 2011;300(1):L25–31. doi: 10.1152/ajplung.00256.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00256.2010</ArticleId><ArticleId IdType="pmc">PMC3023285</ArticleId><ArticleId IdType="pubmed">20971803</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulcher ML, Randell SH. Human nasal and tracheo-bronchial respiratory epithelial cell culture. In: Randell SH, Fulcher ML, editors. Epithelial Cell Culture Protocols. Methods in Molecular Biology. Humana Press; 2012. pp. 109–121.</Citation><ArticleIdList><ArticleId IdType="pubmed">23097104</ArticleId></ArticleIdList></Reference><Reference><Citation>Suprynowicz FA, Upadhyay G, Krawczyk E, Kramer SC, Hebert JD, Liu X, et al. Conditionally reprogrammed cells represent a stem-like state of adult epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 2012;109(49):20035–20040. doi: 10.1073/pnas.1213241109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1213241109</ArticleId><ArticleId IdType="pmc">PMC3523865</ArticleId><ArticleId IdType="pubmed">23169653</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Ory V, Chapman S, Yuan H, Albanese C, Kallakury B, et al. ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells. Am. J. Pathol. 2012;180(2):599–607. doi: 10.1016/j.ajpath.2011.10.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2011.10.036</ArticleId><ArticleId IdType="pmc">PMC3349876</ArticleId><ArticleId IdType="pubmed">22189618</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds SD, Rios C, Wesolowska-Andersen A, Zhuang Y, Pinter M, Happoldt C, et al. Airway progenitor clone formation is enhanced by Y-27632-dependent changes in the transcriptome. Am. J. Respir. Cell Mol. Biol. 2016;55(3):323–336. doi: 10.1165/rcmb.2015-0274MA.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2015-0274MA</ArticleId><ArticleId IdType="pmc">PMC5023026</ArticleId><ArticleId IdType="pubmed">27144410</ArticleId></ArticleIdList></Reference><Reference><Citation>Luengen AE, Kniebs C, Buhl EM, Cornelissen CG, Schmitz-Rode T, Jockenhoevel S, et al. Choosing the right differentiation medium to develop mucociliary phenotype of primary nasal epithelial cells in vitro. Sci. Rep. 2020;10(1):6963. doi: 10.1038/s41598-020-63922-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-63922-8</ArticleId><ArticleId IdType="pmc">PMC7181704</ArticleId><ArticleId IdType="pubmed">32332878</ArticleId></ArticleIdList></Reference><Reference><Citation>Veerati PC, Nichol KS, Read JM, Bartlett NW, Wark PAB, Knight DA, et al. Conditionally reprogrammed asthmatic bronchial epithelial cells express lower FOXJ1 at terminal differentiation and lower IFNs following RV-A1 infection. Am. J. Physiol. Lung Cell Mol. Physiol. 2022;323(4):L495–502. doi: 10.1152/ajplung.00230.2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00230.2022</ArticleId><ArticleId IdType="pmc">PMC9602788</ArticleId><ArticleId IdType="pubmed">36041223</ArticleId></ArticleIdList></Reference><Reference><Citation>Awatade NT, Wong SL, Capraro A, Pandzic E, Slapetova I, Zhong L, et al. Significant functional differences in differentiated conditionally reprogrammed (CRC)- and feeder-free dual SMAD inhibited-expanded human nasal epithelial cells. J. Cyst. Fibros Off J. Eur. Cyst. Fibros Soc. 2021;20(2):364–371. doi: 10.1016/j.jcf.2020.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcf.2020.12.019</ArticleId><ArticleId IdType="pubmed">33414087</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz García S, Deprez M, Lebrigand K, Cavard A, Paquet A, Arguel MJ, et al. Novel dynamics of human mucociliary differentiation revealed by single-cell RNA sequencing of nasal epithelial cultures. Development. 2019;146(20):dev177428. doi: 10.1242/dev.177428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.177428</ArticleId><ArticleId IdType="pmc">PMC6826037</ArticleId><ArticleId IdType="pubmed">31558434</ArticleId></ArticleIdList></Reference><Reference><Citation>Broadbent L, Manzoor S, Zarcone MC, Barabas J, Shields MD, Saglani S, et al. Comparative primary paediatric nasal epithelial cell culture differentiation and RSV-induced cytopathogenesis following culture in two commercial media. PLoS ONE. 2020;15(3):e0228229. doi: 10.1371/journal.pone.0228229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0228229</ArticleId><ArticleId IdType="pmc">PMC7098550</ArticleId><ArticleId IdType="pubmed">32214336</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung C, Wadsworth SJ, Yang SJ, Dorscheid DR. Structural and functional variations in human bronchial epithelial cells cultured in air–liquid interface using different growth media. Am. J. Physiol. Lung Cell Mol. Physiol. 2020;318(5):L1063–L1073. doi: 10.1152/ajplung.00190.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00190.2019</ArticleId><ArticleId IdType="pubmed">32208929</ArticleId></ArticleIdList></Reference><Reference><Citation>Saint-Criq V, Delpiano L, Casement J, Onuora JC, Lin J, Gray MA. Choice of differentiation media significantly impacts cell lineage and response to CFTR modulators in fully differentiated primary cultures of cystic fibrosis human airway epithelial cells. Cells. 2020;9(9):E2137. doi: 10.3390/cells9092137.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9092137</ArticleId><ArticleId IdType="pmc">PMC7565948</ArticleId><ArticleId IdType="pubmed">32967385</ArticleId></ArticleIdList></Reference><Reference><Citation>Livnat G, Meeker JD, Ostmann AJ, Strecker LM, Clancy JP, Brewington JJ. Phenotypic alteration of an established human airway cell line by media selection. Int. J. Mol. Sci. 2023;24(2):1246. doi: 10.3390/ijms24021246.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24021246</ArticleId><ArticleId IdType="pmc">PMC9862772</ArticleId><ArticleId IdType="pubmed">36674762</ArticleId></ArticleIdList></Reference><Reference><Citation>Wark PAB, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J. Exp. Med. 2005;201(6):937–947. doi: 10.1084/jem.20041901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20041901</ArticleId><ArticleId IdType="pmc">PMC2213100</ArticleId><ArticleId IdType="pubmed">15781584</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinovich KM, Iosifidis T, Buckley AG, Looi K, Ling KM, Sutanto EN, et al. Conditionally reprogrammed primary airway epithelial cells maintain morphology, lineage and disease specific functional characteristics. Sci. Rep. 2017;7(1):17971. doi: 10.1038/s41598-017-17952-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-17952-4</ArticleId><ArticleId IdType="pmc">PMC5740081</ArticleId><ArticleId IdType="pubmed">29269735</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid AT, Nichol KS, Chander Veerati P, Moheimani F, Kicic A, Stick SM, et al. Blocking Notch3 signaling abolishes MUC5AC production in airway epithelial cells from individuals with asthma. Am. J. Respir. Cell Mol. Biol. 2020;62(4):513–523. doi: 10.1165/rcmb.2019-0069OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2019-0069OC</ArticleId><ArticleId IdType="pubmed">31922915</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith CM, Djakow J, Free RC, Djakow P, Lonnen R, Williams G, et al. ciliaFA: A research tool for automated, high-throughput measurement of ciliary beat frequency using freely available software. Cilia. 2012;1(1):14. doi: 10.1186/2046-2530-1-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-2530-1-14</ArticleId><ArticleId IdType="pmc">PMC3607980</ArticleId><ArticleId IdType="pubmed">23351276</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu ACY, See HV, Hansbro PM, Wark PAB. Innate immunity to influenza in chronic airways diseases. Respirol. Carlton. Vic. 2012;17(8):1166–1175. doi: 10.1111/j.1440-1843.2012.02200.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1843.2012.02200.x</ArticleId><ArticleId IdType="pubmed">22616906</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu ACY, Dua K, Starkey MR, Haw TJ, Nair PM, Nichol K, et al. MicroRNA-125a and -b inhibit A20 and MAVS to promote inflammation and impair antiviral response in COPD. JCI Insight. 2017;2(7):e90443. doi: 10.1172/jci.insight.90443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.90443</ArticleId><ArticleId IdType="pmc">PMC5374076</ArticleId><ArticleId IdType="pubmed">28405612</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen MD, Mahbub RM, Idrees S, Nguyen DH, Miemczyk S, Pathinayake P, et al. Increased SARS-CoV-2 infection, protease and inflammatory responses in COPD primary bronchial epithelial cells defined with single Cell RNA-sequencing. Am. J. Respir. Crit. Care Med. 2022;10:12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9799113</ArticleId><ArticleId IdType="pubmed">35549656</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee DDH, Petris A, Hynds RE, Ocallaghan C. Ciliated epithelial cell differentiation at air–liquid interface using commercially available culture media. In: Turksen K, editor. Epidermal Cells. Methods in Molecular Biology. Springer; 2019. pp. 275–291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116769</ArticleId><ArticleId IdType="pubmed">31707647</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurer J, Walles T, Wiese-Rischke C. Optimization of primary human bronchial epithelial 3D cell culture with donor-matched fibroblasts and comparison of two different culture media. Int. J. Mol. Sci. 2023;24(4):4113. doi: 10.3390/ijms24044113.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24044113</ArticleId><ArticleId IdType="pmc">PMC9965758</ArticleId><ArticleId IdType="pubmed">36835529</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachs LA, Finkbeiner WE, Widdicombe JH. Effects of media on differentiation of cultured human tracheal epithelium. In Vitro Cell Dev. Biol Anim. 2003;39(1–2):56–62. doi: 10.1290/1543-706X(2003)039&lt;0056:EOMODO&gt;2.0.CO;2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1290/1543-706X(2003)039&lt;0056:EOMODO&gt;2.0.CO;2</ArticleId><ArticleId IdType="pubmed">12892528</ArticleId></ArticleIdList></Reference><Reference><Citation>Ancel J, Belgacemi R, Diabasana Z, Perotin JM, Bonnomet A, Dewolf M, et al. Impaired ciliary beat frequency and ciliogenesis alteration during airway epithelial cell differentiation in COPD. Diagnostics. 2021;11(9):1579. doi: 10.3390/diagnostics11091579.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11091579</ArticleId><ArticleId IdType="pmc">PMC8469815</ArticleId><ArticleId IdType="pubmed">34573921</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsumata M, Fujisawa T, Kamiya Y, Tanaka Y, Kamiya C, Inoue Y, et al. Effects of long-acting muscarinic antagonists on promoting ciliary function in airway epithelium. BMC Pulm. Med. 2022;22(1):186. doi: 10.1186/s12890-022-01983-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-022-01983-3</ArticleId><ArticleId IdType="pmc">PMC9080152</ArticleId><ArticleId IdType="pubmed">35527239</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosoni K, Cassidy D, Kerr B, Land SC, Mehta A. Using drugs to probe the variability of trans-epithelial airway resistance. PLoS ONE. 2016;11(2):e0149550. doi: 10.1371/journal.pone.0149550.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0149550</ArticleId><ArticleId IdType="pmc">PMC4771809</ArticleId><ArticleId IdType="pubmed">26926476</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>